ABUJA, Nigeria – Roche Diagnostics and MedServe, the healthcare subsidiary of the Nigeria Sovereign Investment Authority (NSIA), have signed a five-year agreement to equip 12 laboratory sites across Nigeria with modern diagnostic systems, a move aimed at expanding access to quality healthcare and strengthening the country’s laboratory capacity.
The agreement was signed in Lagos on Friday, where MedServe Managing Director and Chief Executive Officer, Dr Tolulope Adewole, says the partnership is designed to decentralise access to reliable diagnostic services and build a more resilient healthcare system.
“Expanding Nigeria’s diagnostic services is a vital part of building a healthcare system that can respond more effectively to the health needs of its people,” Adewole says.
“This initiative is designed to improve access to modern diagnostic services while strengthening the capacity of laboratories to meet the growing healthcare needs of Nigerians,” he adds.
Roberto Taboada, Network Head for Anglo-West Africa at Roche Diagnostics, says sustainable diagnostic capability depends on strong local partnerships.
“Building lasting diagnostic capability requires strong local partnerships and consistent support through implementation. Working with MedServe allows us to contribute our expertise to a programme shaped around Nigeria’s priorities and the unique needs of its healthcare system.”
Join the conversation